Skip to main content
NCBI home page
Gut logoLink to Gut
. 1991 Mar;32(3):294–298. doi: 10.1136/gut.32.3.294

Natural history and prognostic factors for chronic hepatitis type B.

G Fattovich 1, L Brollo 1, G Giustina 1, F Noventa 1, P Pontisso 1, A Alberti 1, G Realdi 1, A Ruol 1
PMCID: PMC1378837  PMID: 2013423

Abstract

One hundred and five hepatitis B surface antigen (HBsAg) positive patients presenting with chronic persistent hepatitis (n = 46) or chronic active hepatitis without cirrhosis (n = 59) were followed longitudinally for one to 16 years (mean 5.5 years) and underwent follow up biopsy. During a mean histological follow up of 3.7 years, active cirrhosis developed in 21 (20%) patients one to 13 years after entry to the study with a calculated annual incidence of 5.9%. The probability of evolution to cirrhosis was significantly higher in patients with chronic active hepatitis and bridging hepatic necrosis than in those with moderate chronic active hepatitis or chronic persistent hepatitis (p less than 0.0001). Cox multiple regression analysis showed that the following three variables independently implied poor prognosis: older age, presence of bridging hepatic necrosis, and persistence of hepatitis B virus DNA in serum (p less than 0.0001). These findings indicate that patients with severe chronic active hepatitis and persistent hepatitis B virus replication are at very high risk of rapid progression to cirrhosis.

Full text

PDF
294

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acute and chronic hepatitis revisited. Review by an international group. Lancet. 1977 Oct 29;2(8044):914–919. [PubMed] [Google Scholar]
  2. Alberti A., Pontisso P., Fattovich G., Schiavon E., Chemello L., Bortolotti F., Tremolada F., Realdi G. Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients. J Infect Dis. 1986 Oct;154(4):562–569. doi: 10.1093/infdis/154.4.562. [DOI] [PubMed] [Google Scholar]
  3. Aldershvile J., Dietrichson O., Skinhøj P., Kryger P., Mathiesen L. R., Christoffersen P., Nielsen J. O. Chronic persistent hepatitis: serological classification and meaning of the hepatitis B e system. Hepatology. 1982 Mar-Apr;2(2):243–246. doi: 10.1002/hep.1840020209. [DOI] [PubMed] [Google Scholar]
  4. Carman W. F., Jacyna M. R., Hadziyannis S., Karayiannis P., McGarvey M. J., Makris A., Thomas H. C. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989 Sep 9;2(8663):588–591. doi: 10.1016/s0140-6736(89)90713-7. [DOI] [PubMed] [Google Scholar]
  5. Cooksley W. G., Bradbear R. A., Robinson W., Harrison M., Halliday J. W., Powell L. W., Ng H. S., Seah C. S., Okuda K., Scheuer P. J. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology. 1986 May-Jun;6(3):345–348. doi: 10.1002/hep.1840060302. [DOI] [PubMed] [Google Scholar]
  6. De Groote J., Fevery J., Lepoutre L. Long-term follow-up of chronic active hepatitis of moderate severity. Gut. 1978 Jun;19(6):510–513. doi: 10.1136/gut.19.6.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dudley F. J., Scheuer P. J., Sherlock S. Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet. 1972 Dec 30;2(7792):1388–1393. doi: 10.1016/s0140-6736(72)92963-7. [DOI] [PubMed] [Google Scholar]
  8. Fattovich G., Brollo L., Alberti A., Pontisso P., Giustina G., Realdi G. Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology. 1988 Nov-Dec;8(6):1651–1654. doi: 10.1002/hep.1840080630. [DOI] [PubMed] [Google Scholar]
  9. Fattovich G., Rugge M., Brollo L., Pontisso P., Noventa F., Guido M., Alberti A., Realdi G. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology. 1986 Mar-Apr;6(2):167–172. doi: 10.1002/hep.1840060203. [DOI] [PubMed] [Google Scholar]
  10. Ferrari C., Penna A., Giuberti T., Tong M. J., Ribera E., Fiaccadori F., Chisari F. V. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol. 1987 Sep 15;139(6):2050–2058. [PubMed] [Google Scholar]
  11. Ginés P., Quintero E., Arroyo V., Terés J., Bruguera M., Rimola A., Caballería J., Rodés J., Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987 Jan-Feb;7(1):122–128. doi: 10.1002/hep.1840070124. [DOI] [PubMed] [Google Scholar]
  12. Hadziyannis S. J., Lieberman H. M., Karvountzis G. G., Shafritz D. A. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus. Hepatology. 1983 Sep-Oct;3(5):656–662. doi: 10.1002/hep.1840030505. [DOI] [PubMed] [Google Scholar]
  13. Hsu H. C., Su I. J., Lai M. Y., Chen D. S., Chang M. H., Chuang S. M., Sung J. L. Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection. J Hepatol. 1987 Aug;5(1):45–50. doi: 10.1016/s0168-8278(87)80060-0. [DOI] [PubMed] [Google Scholar]
  14. Liaw Y. F., Chu C. M., Lin D. Y., Sheen I. S., Yang C. Y., Huang M. J. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Med Virol. 1984;13(4):385–391. doi: 10.1002/jmv.1890130410. [DOI] [PubMed] [Google Scholar]
  15. Liaw Y. F., Tai D. I., Chu C. M., Chen T. J. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology. 1988 May-Jun;8(3):493–496. doi: 10.1002/hep.1840080310. [DOI] [PubMed] [Google Scholar]
  16. Lo K. J., Tong M. J., Chien M. C., Tsai Y. T., Liaw Y. F., Yang K. C., Chian H., Liu H. C., Lee S. D. The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan. J Infect Dis. 1982 Aug;146(2):205–210. doi: 10.1093/infdis/146.2.205. [DOI] [PubMed] [Google Scholar]
  17. Mondelli M., Vergani G. M., Alberti A., Vergani D., Portmann B., Eddleston A. L., Williams R. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol. 1982 Dec;129(6):2773–2778. [PubMed] [Google Scholar]
  18. Realdi G., Alberti A., Rugge M., Bortolotti F., Rigoli A. M., Tremolada F., Ruol A. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology. 1980 Aug;79(2):195–199. [PubMed] [Google Scholar]
  19. Sánchez-Tapias J. M., Costa J., Mas A., Parés A., Bruguera M., Rodés J. Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B. J Hepatol. 1988 Feb;6(1):15–22. doi: 10.1016/s0168-8278(88)80458-6. [DOI] [PubMed] [Google Scholar]
  20. Viola L. A., Barrison I. G., Coleman J. C., Paradinas F. J., Fluker J. L., Evans B. A., Murray-Lyon I. M. Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain. Lancet. 1981 Nov 21;2(8256):1156–1159. doi: 10.1016/s0140-6736(81)90600-0. [DOI] [PubMed] [Google Scholar]
  21. Williams A. L., Hoofnagle J. H. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology. 1988 Sep;95(3):734–739. doi: 10.1016/s0016-5085(88)80022-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES